LAUSANNE, Switzerland, Feb. 18, 2026 (GLOBE NEWSWIRE) -- NewBiologix S.A., a biotechnology company advancing recombinant adeno-associated virus (rAAV) production through next-generation clonal HEK293 ...

The Vector W8 occupies a peculiar place in automotive memory, at once a cult object and a cautionary tale. It promised an ...

Aledade added more than 700 primary care practices to its network for 2026 as the company sees strong tailwinds for ...

Wilding Gold Project (~5,000m planned): Initial field program consisting of ~250 percussion drill holes (basal till and ...

Henry Ford Health has treated the first Michigan patient outside clinical trials with Roctavian, the newly approved gene ...

The patient, who is in his 30s, got the one-time intravenous infusion at the Infusion and Chemotherapy Treatment Center at ...

How can we explain the new and simultaneous presence of worms, notoriously slow animals, in gardens distant from each other and without the introduction of new plants? An original answer is ...

Anopheles mosquitoes are central to the global battle against malaria and Bill Gates, through the Bill Melinda Gates ...

More than 30 Texas companies, including some around San Antonio and Austin, are part of a Pentagon program that Homeland ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

Bracco’s cell selection and activation microbubble technology is designed to support both positive- and negative-selection strategies.

Krystal Biotech received FDA RMAT designation for inhaled KB707 in advanced NSCLC, based on a 36% ORR in heavily pretreated ...